tetano
Editor, Senior Moderator
J Infect
. 2021 Feb 18;S0163-4453(21)00090-6.
doi: 10.1016/j.jinf.2021.02.020. Online ahead of print.
A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave
Sarah Denny[SUP] 1 [/SUP], Alireza Abdolrasouli[SUP] 2 [/SUP], Tamador Elamin[SUP] 3 [/SUP], Ximena Gonzalo[SUP] 4 [/SUP], Scott Pallett[SUP] 5 [/SUP], Esmita Charani[SUP] 6 [/SUP], Aatish Patel[SUP] 7 [/SUP], Hugo Donaldson[SUP] 8 [/SUP], Stephen Hughes[SUP] 7 [/SUP], Darius Armstrong-James[SUP] 9 [/SUP], Luke Sp Moore[SUP] 10 [/SUP], Nabeela Mughal[SUP] 10 [/SUP]
Affiliations
No abstract availableKeywords: Coronavirus; Microbiology: Candidaemia; SARS-CoV-2.
Conflict of interest statement
Declaration of competing interests SC has received a research grants from the Scientific Exploration Society. EC has been paid for consultancy fees by bioMerieux. SH reports personal fees from Pfizer and Shionogi. DAJ holds share options in Pulmocide Ltd and has received research grants from Pulmocide Ltd, Gilead Sciences, Astellas and Pfizer. He has received speaker and consultancy fees from Astra-Zeneca, Pfizer, Gilead, and Astellas. LSPM has consulted for DNAelectronics (2015-18), Dairy Crest (2017–2018), Umovis Lab (2020), bioMerieux (2013-2020), received speaker fees from Profile Pharma (2018) and Pfizer (2018-2020), received research grants from the National Institute for Health Research (2013-2020), CW+ Charity (2018-2020), and Leo Pharma (2016), and received educational support from Eumedica (2016–2018). NM has received speaker fees from Beyer (2016) and Pfizer (2019) and received educational support from Eumedica (2016) and Baxter (2017). All other authors have no conflicts of interest to declare.
. 2021 Feb 18;S0163-4453(21)00090-6.
doi: 10.1016/j.jinf.2021.02.020. Online ahead of print.
A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave
Sarah Denny[SUP] 1 [/SUP], Alireza Abdolrasouli[SUP] 2 [/SUP], Tamador Elamin[SUP] 3 [/SUP], Ximena Gonzalo[SUP] 4 [/SUP], Scott Pallett[SUP] 5 [/SUP], Esmita Charani[SUP] 6 [/SUP], Aatish Patel[SUP] 7 [/SUP], Hugo Donaldson[SUP] 8 [/SUP], Stephen Hughes[SUP] 7 [/SUP], Darius Armstrong-James[SUP] 9 [/SUP], Luke Sp Moore[SUP] 10 [/SUP], Nabeela Mughal[SUP] 10 [/SUP]
Affiliations
- PMID: 33610684
- DOI: 10.1016/j.jinf.2021.02.020
No abstract availableKeywords: Coronavirus; Microbiology: Candidaemia; SARS-CoV-2.
Conflict of interest statement
Declaration of competing interests SC has received a research grants from the Scientific Exploration Society. EC has been paid for consultancy fees by bioMerieux. SH reports personal fees from Pfizer and Shionogi. DAJ holds share options in Pulmocide Ltd and has received research grants from Pulmocide Ltd, Gilead Sciences, Astellas and Pfizer. He has received speaker and consultancy fees from Astra-Zeneca, Pfizer, Gilead, and Astellas. LSPM has consulted for DNAelectronics (2015-18), Dairy Crest (2017–2018), Umovis Lab (2020), bioMerieux (2013-2020), received speaker fees from Profile Pharma (2018) and Pfizer (2018-2020), received research grants from the National Institute for Health Research (2013-2020), CW+ Charity (2018-2020), and Leo Pharma (2016), and received educational support from Eumedica (2016–2018). NM has received speaker fees from Beyer (2016) and Pfizer (2019) and received educational support from Eumedica (2016) and Baxter (2017). All other authors have no conflicts of interest to declare.